Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 4c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.71), $0.04 better than the analyst estimate of ($0.75).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
• Spotify (SPOT) PT Lowered to $531 at Rosenblatt
• Buckle reports 5.2% net sales rise for fiscal June 2026